Objectives: In Klebsiella pneumoniae, overproduction of RamA results in reduced envelope permeability and reduced antimicrobial susceptibility but clinically relevant resistance is rarely observed. Here we have tested whether RamA overproduction can enhance acquired b-lactam resistance mechanisms in K. pneumoniae and have defined the envelope protein abundance changes upon RamA overproduction during growth in low and high osmolarity media.
Introduction
RamA is a global transcriptional activator 1 found in, amongst other Enterobacteriaceae: Salmonella spp., 2 Enterobacter spp. 1, 3 and Klebsiella spp. 1, 4 but not Escherichia coli. Where characterized, RamA has revealed a function comparable to that of E. coli MarA. [1] [2] [3] [4] [5] In WT Klebsiella pneumoniae, at least during standard laboratory growth, RamA production is low because the transcriptional repressor, RamR, occludes the ramA promoter. 6 In some clinical isolates, RamA is overproduced due to de-repressing mutations in ramR. [7] [8] [9] [10] RamA activates the transcription of a regulon including oqxAB, acrAB and tolC, encoding components of two tripartite antimicrobial efflux pumps. 4 Overexpression of ramA in K. pneumoniae isolates that lack other resistance mechanisms increases the MICs of a wide range of antimicrobials, including cephalosporins but not carbapenems.
However, even overexpressing ramA .1000-fold only confers resistance to one or two antimicrobials and only in some isolates. 5 On its own, therefore, RamA is not a key resistance determinant in K. pneumoniae, but clinical isolates can carry acquired resistance mechanisms, particularly plasmid-encoded b-lactamases. 11 Accordingly, the first aim of this work was to determine whether RamA overproduction can enhance the spectrum of resistance conferred by acquired b-lactamases. We also wanted to test how common ramR loss-of-function mutations are in K. pneumoniae clinical isolates having different b-lactam resistance phenotypes.
We were particularly keen to investigate whether reduced carbapenem susceptibility occurs in RamA-overproducing K. pneumoniae having ESBL or AmpC-type cephalosporinases. This was because RamA overproduction and porin loss both reduce envelope permeability, and because porin loss has previously been shown to increase carbapenem MICs for K. pneumoniae isolates producing ESBLs or AmpC cephalosporinases. 12 Enhancement of b-lactam MICs seen following OmpK35 porin loss in a cephalosporinase-producing K. pneumoniae is reportedly minimized during growth in high osmolarity Mueller-Hinton medium, 12 which is the medium of choice for most antibiotic susceptibility testing protocols, 13 but is maximized during growth in low osmolarity nutrient media. This is because these media reportedly support different basal OmpK35 levels. 12 Subsequently, we also set out to define the envelope proteome changes stimulated by RamA overproduction in Mueller-Hinton broth (MHB) and nutrient broth (NB) using Orbitrap LC-MS/MS. The aim was to identify common and growth medium-specific effects of RamA overproduction, and to confirm a previous report that basal OmpK35 levels are different in the two media. 12 Finally, we set out to define the contribution of RamA-mediated OmpK35 down-regulation 4, 5 to the overall effect of RamA overproduction on envelope permeability and antibiotic susceptibility in K. pneumoniae.
Materials and methods
Bacterial strains and antibiotic susceptibility testing E. coli TOP10 (Invitrogen, Leek, The Netherlands), 44 non-replicate K. pneumoniae human clinical isolates having various antimicrobial susceptibility profiles (provided by Dr Karen Bowker, Department of Microbiology, North Bristol NHS Trust), K. pneumoniae NCTC 5055 transformants carrying pBAD (ramA) or a pBAD vector-only control plasmid 5 and the otherwise isogenic pair Ecl8 and Ecl8DramR 4 were used throughout. Disc susceptibility testing was performed according to CLSI methodology 13 and interpreted using CLSI performance standards.
14 Cloning plasmid-mediated b-lactamase genes and micF and sequencing ramR Cloning bla NDM-1 (with its ISAba125 promoter) into the cloning vector pSU18 15 has previously been reported. 16 K. pneumoniae micF and the following additional b-lactamase genes were synthesized or amplified by PCR from the sources and using the primers listed in Table S1 (available as Supplementary data at JAC Online) and the PCR method previously described 17 in such a way as to include their native promoters: bla IMP-1 and bla VIM-1 (with hybrid and weak strength class 1 integron promoters, respectively), 18 bla CTX-M1 and bla CMY-4 (with ISEcp1 promoters), bla KPC-3 (with an ISKpn7 promoter) and bla OXA-48 (with an IS1999 promoter). Some PCR amplicons were TA cloned into the pCR2.1-TOPO cloning vector (Invitrogen) according to the manufacturer's instructions. These pCR2.1 inserts, removed by restriction enzyme digestion, and other PCR amplicons directly cut with restriction enzymes, were ligated into the pSU18 15 or pK18 19 cloning vectors as illustrated in Table S1 . Plasmids were used to transform K. pneumoniae isolates to chloramphenicol or kanamycin (30 mg/L) resistance for pSU18 and pK18, respectively, using electroporation as standard for lab strain E. coli. To sequence ramR from clinical isolates, the gene was amplified using PCR as previously described 17 and sequenced; primers are recorded in Table S1 . Sequence alignment and analysis were performed using the online ClustalOmega (http://www. ebi.ac.uk/Tools/msa/clustalo/) tool; the reference sequence used was K. pneumoniae Ecl8 (accession number HF536482.1).
Growth of cultures for all experiments
Each isolate or transformant was inoculated into a separate batch of 50 mL of cation-adjusted MHB (Sigma) or NB (Oxoid) containing appropriate selection in a 250 mL foam-stoppered flask to an initial OD at 600 nm (OD 600 ) of 0.05. Cultures were incubated with shaking (160 rpm) until the OD 600 had reached 0.5-0.7.
Fluorescent Hoechst (H) 33342 dye accumulation assay
Envelope permeability was estimated as described previously 5 in bacteria grown in liquid culture using an established fluorescent dye accumulation assay 20 with black flat-bottomed 96-well plates (Greiner Bio-one, Stonehouse, UK) and a Fluostar Optima (Aylesbury, UK) plate reader. H33342 (Sigma) was used at a final concentration of 2.5 lM.
Characterization of envelope proteomes and real-time RT-PCR
Methods used for protein and RNA extraction and analysis of abundance were almost identical to those used previously 5 and are presented in detail in the Supplementary data. For each LC-MS/MS proteomics experiment, raw protein abundance data were collected for three biological replicates of each growth condition. The significance of any observed difference between the means of the triplicate abundance data for one protein in two different growth conditions was calculated using a t-test comparing the raw abundance data as described in the Supplementary data.
b-Lactamase assays and multiplex PCR for b-lactamase gene carriage
Multiplex PCRs were performed for: (i) carbapenemase genes encoding the IMP, VIM, OXA-48-like, NDM and KPC enzymes, 21 though the NDM and OXA-48-like gene-identifying PCRs were run separately and not as a multiplex with the rest; (ii) genes encoding CTX-M groups 1, 2, 8, 9 and 25; 22 and (iii) genes encoding TEM-1, SHV, OXA-1 and CMY. All multiplex PCR primers and expected product sizes are recorded in Table S2 . The DNA template was prepared as previously described 17 and 1 lL of supernatant was used in a final PCR volume of 25 lL of consisting of 12.5 lL of REDTaq ReadyMix (Sigma) with 10 lM of each primer. PCR was performed using the following conditions: 94 C for 10 min, 35 cycles of amplification consisting of 94 C for 1 min, 52-56 C for 1 min, 72 C for 1 min 30 s and a final extension at 72 C for 10 min.
b-Lactamase assays were performed as follows: overnight cultures of bacteria were diluted to an OD 600 of 0.1 in MHB and grown at 37 C until the OD 600 was 0.8 before cell extracts were prepared and levels of b-lactamase activity in cell extracts measured as described previously 23 using 100 lM nitrocefin as the substrate. Linear gradients (DAU/min) were extrapolated and an extinction coefficient of 17400 AU/M was used to calculate nitrocefin hydrolysing activity. The total protein concentration in each cell extract was quantified using the Bio-Rad protein assay reagent (Bio-Rad, Hemel Hempstead, UK) according to the manufacturer's instructions and used to calculate relative specific enzyme activity (pmol/min/lg) in each cell extract.
Results and discussion
Enhancement of b-lactam resistance in K. pneumoniae by RamA in the presence of acquired b-lactamases A library of seven clinically important mobile b-lactamase genes was created using pSU18, a low-copy number vector. 15 Each gene was expressed from a promoter commonly seen in clinical isolates to give close to WT levels of b-lactamase production (see Table S1 ). This library was used to transform K. pneumoniae Ecl8 and Ecl8DramR, and there was no significant difference in b-lactamase production in Ecl8DramR versus Ecl8 transformants (Table S3) .
RamA-enhanced b-lactam resistance in Klebsiella pneumoniae JAC Ecl8 was susceptible to 17 of 18 tested b-lactams (Table 1) . Overproduction of RamA (i.e. Ecl8DramR) reduced zone diameters 2 mm for 13 of 18 tested b-lactams, but clinically relevant non-susceptibility 14 was not achieved for any except ampicillin ( Table 1) . The MBLs NDM-1 and IMP-1 rendered Ecl8 non-susceptible to 17 of 18 and 14 of 18 b-lactams, respectively, so the additional effect of RamA overproduction was difficult to see (Table 1) . Accordingly, bla VIM-1 was cloned with a weak integron promoter and the resultant low-level MBL production meant that Ecl8 remained susceptible to 12 of 18 test b-lactams. Here, the effect of RamA overproduction was profound. Ecl8DramR (VIM-1) was only susceptible to aztreonam and cefotetan (Table 1) .
RamA overproduction also affected b-lactam susceptibility in the presence of serine b-lactamases. There was a considerable zone diameter reduction for ertapenem (by 7 mm; on the verge of being non-susceptible) in Ecl8DramR (CTX-M1) versus Ecl8 (CTX-M1) but for the other carbapenems, no change at all. In the case of the AmpC-type serine b-lactamases, ertapenem non-susceptibility was conferred in Ecl8DramR (CMY-4), though the other carbapenems remained equally active as against Ecl8 (CMY-4). In Ecl8 (KPC-3), only the cephamycins retained activity, but even these were lost in Ecl8DramR (KPC-3). In contrast, the effect of carrying OXA-48 was relatively weak. When RamA was overproduced there was a slight reduction in inhibition zone diameter, particularly for the carbapenems, but Ecl8DramR (OXA-48) remained susceptible to 17 of 18 b-lactams (Table 1) .
Survey of ramR function in clinical isolates carrying or not carrying cephalosporinases and carbapenemases
Forty-four K. pneumoniae clinical isolates were randomly collected (Table S4) . Twenty isolates carried a ramR allele encoding a Thr141Ile variant (in comparison with Ecl8), which has no impact on phenotype. 9 Two isolates encoded the Ala19Val RamR variant, which is also functionally silent. 24 Seven other isolates encoded RamR protein variants and real-time RT-PCR was used to measure ramA transcript levels in these seven isolates in comparison with the ramR WT isolate AH. Six of the RamR variant isolates hyperexpressed ramA; the Ile106Ser variant was not associated with significantly higher ramA expression (Table S4) .
Three multiplex PCRs were performed to categorize the b-lactamase genes present in each of the 44 clinical isolates. Four carried at least one carbapenemase gene, of which 2 also carried bla CTX-M ; 21 additional isolates carried bla CTX-M . All CTX-M genes were of group 1. The remaining 19 isolates did not carry any cephalosporinase or carbapenemase gene (Table S4) .
Finally, disc susceptibility testing was performed for eight b-lactams against the 44 clinical isolates. Using the sum of all the inhibition zone diameters to represent the combined b-lactam susceptibility for each isolate, we ranked the isolates (Table S4) . Not surprisingly, the four carbapenemase-positive isolates were the least b-lactam susceptible. Interestingly, three of four of these isolates also carry a ramR mutation and hyperexpress ramA. Only 1 of the 21 carbapenemase-negative, CTX-M-positive isolates hyperexpressed ramA, but this isolate (isolate T) was by far the least susceptible in this group. As predicted from our Assays were performed using Mueller-Hinton agar according to the CLSI protocol 13 for K. pneumoniae Ecl8 and Ecl8DramR (D). Values reported are the means of three repetitions rounded to the nearest integer. Zones confirming non-susceptibility are shaded grey. Susceptibility breakpoints are as set by the CLSI. transformation experiments, isolate T displayed reduced carbapenem susceptibility relative to the 20 isolates that have CTX-M but an intact ramR. However, this effect (Table S4 ) was greater than that seen in the Ecl8/Ecl8DramR transformants (Table 1) , with resistance to ertapenem and intermediate resistance to doripenem being observed in isolate T, together with reduced susceptibility to meropenem, suggesting an additional as yet uncharacterized mechanism in isolate T. As seen with Ecl8DramR (Table 1) , ramA hyperexpression in the two clinical isolates (isolates N and AO) that lack any cephalosporinase or carbapenemase genes had minimal impact on b-lactam susceptibility (Table S4) Envelope proteome changes following RamA overproduction in K. pneumoniae in NB and MHB and impact on envelope permeability
We have recently shown that RamA overproduction in K. pneumoniae NCTC 5055 using a pBAD expression plasmid increased AcrABTolC and OqxAB-TolC efflux pump production. 5 To obtain a more detailed understanding of the RamA regulon, we used Orbitrap LC-MS/MS proteomics. Table S5 shows summary data for the Ecl8/Ecl8DramR pair during growth in MHB. It has previously been reported that low osmolarity media such as NB affect the levels of OmpK35 relative to growth in high osmolarity media such as MHB. 12 This observation is potentially important because OmpK35 levels might impact on envelope permeability and because antimicrobial susceptibility assays are generally performed using Mueller-Hinton medium. Accordingly, to see whether medium osmolarity affects the impact of RamA overproduction, we also determined envelope proteome changes in the Ecl8/Ecl8DramR pair during growth in NB (Table S6) .
Our LC-MS/MS methodology allowed identification and absolute quantification with a high degree of certainty (3 peptides identified) of 655 and 494 proteins in envelope preparations from cells grown in MHB and NB, respectively. Previous data from SDS-PAGE analysis of outer membrane protein preparations have been interpreted as meaning that OmpK35 levels increase relative to OmpK36 levels upon shifting from MHB to NB, 12 and our LC-MS/MS data confirmed this finding. There is a shift in the OmpK36:OmpK35 ratio in Ecl8 from 1.7:1 (calculated from mean protein abundance data, P " 0.013, n " 3) during growth in MHB to 1.1:1 (P " 0.45, n " 3) during growth in NB. Our accurate absolute abundance data revealed that this change in OmpK36:OmpK35 ratio is achieved through down-regulation of OmpK36 (2.2-fold, P " 0.011, n " 3) not up-regulation of OmpK35 (0.7-fold, P " 0.16, n " 3) during growth in NB relative to growth in MHB.
Twenty-nine and 33 proteins were found to be 2-fold up-or down-regulated in Ecl8DramR versus Ecl8 following application of our statistical significance cut-off (P , 0.05 for a t-test comparing absolute protein abundance data, n " 3) during growth in MHB and NB, respectively (Tables S5 and S6 ). Of these, 12 proteins were similarly regulated in both media; 11 up-regulated, with only OmpK35 down-regulated ( Table 2 ). Ten of 11 proteins up-regulated in Ecl8DramR in both media were also up-regulated in K. pneumoniae strain NCTC 5055 following overproduction of RamA via the pBAD expression plasmid (Table S7 ). These 10 core up-regulated proteins represent two efflux pumps (AcrAB and OqxAB, together with the outer membrane efflux protein TolC). The remaining proteins are poorly characterized and neither their precise role in RamA-mediated reduced antimicrobial susceptibility nor their direct control by RamA can be confirmed at this time.
Of the medium-specific impacts of RamA overproduction, two are striking. In MHB only, down-regulation of several proteins encoded by the maltose transport operon occurs (Table  S5 ). The LamB2 porin is amongst these. Interestingly, its loss by mutation has been implicated in reduced carbapenem entry in K. pneumoniae, 25, 26 so it is conceivable that down-regulation of LamB2 might enhance the impact of RamA overproduction on carbapenem MICs during growth on Mueller-Hinton agar, which is apparent in the presence of certain plasmid-mediated b-lactamases (Table 1 and Table S4 ). In NB only, the efflux pump AcrEF is up-regulated in Ecl8DramR relative to Ecl8. Whilst this Methodology and details of data analysis are described in the Supplementary data. Where protein goes from being undetectable to being detectable in parent versus mutant, a nominal fold change of .20 and P , 0.001 have been applied, as described previously.
pump has not been specifically characterized in K. pneumoniae, its equivalent has a role in antimicrobial resistance in other enteric bacteria, and it is part of the Salmonella Typhimurium RamA regulon. 2 Also up-regulated in NB only are the transporter complex proteins YrbCDEF (Table S6) . RamA-mediated regulation of the yrb locus has previously been demonstrated using transcriptome analyses in both K. pneumoniae 4 and Salmonella Typhimurium 2 and a potential RamA binding site has been proposed for the yrb locus in K. pneumoniae. 4 YrbCDEF from Ecl8 are .90% identical to the MlaCDEF proteins, part of the MlaABCDEF ABC transporter from E. coli, which has recently been shown to play an important role in retrograde phospholipid trafficking. The perturbation of the phospholipid content of the outer membrane is likely to result in a reduction in its sensitivity to chemical damage, and may affect antimicrobial/cell affinity, reducing rate of entry. [27] [28] [29] The AcrEF and Yrb (Mla) proteins were also up-regulated following RamA overproduction from the pBAD expression vector in K. pneumoniae NCTC, but LamB2 is not downregulated (Table S7 ). These NCTC 5055 data were collected during growth in NB, which explains these findings, and confirms the medium dependence of the effects. Despite these differences in envelope proteome seen during growth of Ecl8DramR in MHB and NB, there is little impact of growth medium on RamA-mediated envelope permeability reduction. When measured using fluorescent dye accumulation, envelope permeability reduces by 75% in Ecl8DramR versus Ecl8 during growth in MHB and 65% during growth in NB (Figure 1a) .
Overall, based on our test of significance, 51 proteins were differentially regulated in NCTC 5055 carrying pBAD (ramA) versus the pBAD control transformant during growth in the presence of 0.2% (w/v) arabinose, which stimulates RamA overproduction (Table S7 ). This is more than the number of proteins differentially regulated in Ecl8DramR versus Ecl8 (Tables S5 and S6 ). However, according to real-time RT-PCR analysis, there was 9200+390-fold (mean + SEM, n " 3) more ramA transcript in NCTC 5055::pBAD (ramA) than in NCTC 5055::pBAD (control) when grown in the presence of 0.2% (w/v) arabinose, as shown previously. 5 This is dramatically more than that seen for the 'natural' RamAoverproducing mutant Ecl8DramR, where there is 6.7+2.2-fold (mean + SEM, n " 3) more ramA transcript than in Ecl8, and 100-fold more than even the most ramA-overexpressing clinical isolate in our collection (Table S4) . Hence, the additional proteomic Jiménez-Castellanos et al.
differences seen in NCTC:pBAD (ramA) are likely to be due to spurious occupation of regulatory binding sites by the greatly overproduced RamA, which has previously been reported in Salmonella.
2
Role of micF in RamA-mediated control of OmpK35 levels
There is clear down-regulation of OmpK35 porin production following RamA overproduction in Ecl8 (Table 2) . By analogy with the situation in E. coli following overproduction of MarA, 30 reduction of OmpK35 levels in K. pneumoniae is likely to be due to transcriptional up-regulation of micF by RamA. To test this, we cloned the micF gene, with its own promoter, into a high-copy vector pK18 19 and used this recombinant to boost micF transcript levels in trans in Ecl8. LC-MS/MS confirmed that OmpK35 levels were down-regulated (0.39-fold, P " 0.005, n " 3) in Ecl8(micF) compared with Ecl8(pK18) during growth in MHB; almost the same down-regulation seen in Ecl8DramR compared with Ecl8 during growth in MHB (0.43-fold, P " 0.007, n " 3). However, dye accumulation assays unexpectedly revealed that steady-state accumulation of the fluorescent dye is 20% more in Ecl8(micF) than in the Ecl8(pK18) control transformant, suggesting an increase in envelope permeability in the micF-overexpressing recombinant (Figure 1b) . Disc susceptibility testing confirmed that this is sufficient to increase antibiotic inhibition zones against Ecl8(micF) ( Table S8) .
We hypothesized that the reason for this increase in envelope permeability (Figure 1b) despite OmpK35 levels being reduced is that K. pneumoniae responds by down-regulating efflux pump production or up-regulating porin production to balance envelope permeability. A reciprocal effect, i.e. down-regulation of OmpK35 in K. pneumoniae having reduced AcrAB-TolC-mediated efflux, has recently been reported. 31 In support of our hypothesis, real-time RT-PCR showed that acrA levels are reduced in Ecl8(micF) versus Ecl8(pK18) [0.53+0.07-fold (mean + SEM, n " 3)]; LC/MS-MS confirmed that this led to a reduction in AcrA protein levels (0.62-fold, P " 0.05, n " 3). No porin proteins were seen to be up-regulated in the proteomics data (not shown). In fact, OmpK36 and OmpA are down-regulated (respectively, 0.57-fold, P " 0.02, n " 3 and 0.61-fold, P " 0.03, n " 3).
Interestingly, down-regulation of ramA transcription was seen using real-time RT-PCR in Ecl8(micF) compared with Ecl8(pK18) [0.09+0.04-fold (mean + SEM, n " 3)]. It is possible, therefore, that RamA down-regulation may be responsible for the downregulation of AcrA seen in response to micF-mediated OmpK35 down-regulation. If correct, this is suggestive of a feedback mechanism by which the cell can sense the balance of different factors affecting envelope permeability and controls RamA production as necessary.
Conclusions
RamA overproduction in K. pneumoniae has been associated with resistance to specific antimicrobials, e.g. tigecycline.
9, 24 We conclude that RamA overproduction is predominantly mediated by efflux pump overproduction and can be selected in isolates with acquired b-lactamases, which are very common in the clinic. The effect on carbapenem resistance in K. pneumoniae carrying a weakly expressed bla VIM-1 gene was particularly pronounced, and it was striking to see ramA hyperexpression in three of four carbapenemase-producing bloodstream isolates from a collection (Table S4) . It was also particularly concerning to see the generation of ertapenem resistance following loss of RamR repressor activity in combination with an AmpC-type enzyme in Ecl8 (Table 1 ) and in a ramA-overexpressing clinical isolate carrying CTX-M (Table S4 ). There may be other ways by which RamA overproduction can be beneficial; e.g. it may be a prerequisite for the selection of other resistance-causing mutation events such as target site mutations or those that cause porin loss.
